Additive cytotoxic effect of bortezomib in combination with anti-CD20 or anti-CD52 monoclonal antibodies on chronic lymphocytic leukemia cells
Piotr Smolewski, Markus Duechler, Anna Linke, Barbara Cebula, Olga Grzybowska-Izydorczyk, Medhat Shehata, Tadeusz RobakVolume:
30
Year:
2006
Language:
english
Pages:
9
DOI:
10.1016/j.leukres.2006.03.005
File:
PDF, 580 KB
english, 2006